Piper chaba mediated synthesis of silver nanoparticles to control multidrug-resistant diarrheagenic fecal pathogens

利用胡椒属植物介导的银纳米粒子合成控制多重耐药性致泻性粪便病原体

阅读:1

Abstract

Plant-mediated biosynthesis of nanoparticles has gained significant attention in Biomedical fields. This study focused on the isolation of multidrug-resistant diarrheagenic fecal pathogens and their control by green-synthesized silver nanoparticles. Furthermore, we assessed the antioxidant and cytotoxic properties of Piper chaba leaf-synthesized nanoparticles. We isolated and identified multiple antibiotic-resistant fecal pathogens, including Enterococcus gallinarum, Klebsiella pneumoniae, and Escherichia coli, through biochemical assays and 16S rRNA gene sequencing. Then the synthesis of silver nanoparticles was visually confirmed by a color change in the sample solutions and further confirmed through UV-Vis spectroscopy, FTIR, TEM, DLS, and XRD analyses. UV-Vis spectroscopy revealed a surface plasmon resonance (SPR) peak at 440 nm. Meanwhile, FTIR analysis identified functional groups such as haloalkanes, alkenes, and alcohols contributing to the synthesis and stabilization of the nanoparticles. DLS showed the nanoparticles were 56.66 nm in size with monodispersity, and XRD confirmed the presence of face-centered cubic crystals with an average size of 16.06 nm. Furthermore, TEM images showed spherical-shaped nanoparticles at various resolutions. The DPPH (2, 2-diphenyl-1-picrylhydrazyl) assay indicated antioxidant activity, with a maximum radical scavenging activity (% RSA) of 69.28 %. In addition, the brine shrimp lethality assay (BSLA) demonstrated low cytotoxicity with an LC(50) value of 912.01 μg/mL. The nanoparticles effectively inhibited these multidrug-resistant pathogens at varying doses, with minimum inhibitory concentrations of 4 μg/mL against Klebsiella pneumoniae and Escherichia coli, and 16 μg/mL against Enterococcus gallinarum. These findings suggest that green-synthesized silver nanoparticles could be a promising therapeutic approach for controlling antibiotic-resistant fecal pathogens.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。